The agreement gives OrthoPediatrics, a pediatric orthopedic devicemaker, exclusivity in distributing 3D-Side’s 3D-Cut-Osteo to U.S. pediatric hospitals and, in the future, internationally, according to a July 13 press release.
These 3D guides offer surgeons assistance in performing corrective and bone tumor osteotomies by creating a patient-specific guide using CT or MRI images.
“The 3D-Side technology complements the OrthoPediatrics’ pediatric limb deformity implant and biologic offering, and increases exposure in the pediatric oncology market, where many of the most challenging orthopedic cases involving tumor resection require a full complement of solutions including implants, biologics and patient-specific devices,” OrthoPediatrics CEO David Bailey said in the press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.